ISSN 2147-9720 | E-ISSN 2148-4279
Skin imaging in systemic sclerosis
(Eur J Rheumatol 2014; 1: 111-116)
DOI: 10.5152/eurjrheumatol.2014.036
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
(Eur J Rheumatol 2016; 3: 75-84)
DOI: 10.5152/eurjrheum.2015.0085
Case Report
Thrombocytopenia caused by albendazole in a patient with Sjögren’s syndrome: A case report
(Eur J Rheumatol 2014; 1: 44-45)
DOI: 10.5152/eurjrheum.2014.009
A severe case of systemic lupus erythematosus with increased pressure communicating hydrocephalus
(Eur J Rheumatol 2015; 2: 76-77)
DOI: 10.5152/eurjrheum.2015.0084
Refractory anemia in systemic sclerosis: myelodisplastic syndrome
(Eur J Rheumatol 2015; 2: 120-121)
DOI: 10.5152/eurjrheum.2015.0100
Spontaneous patellar tendon rupture in a case followed up for diagnosis of systemic lupus erythematosus
(Eur J Rheumatol 2014; 1: 159-160)
DOI: 10.5152/eurjrheumatol.2014.140044
Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in a patient with systemic lupus erythematosus and lupus nephritis
(Eur J Rheumatol 2016; 3: 36-37)
DOI: 10.5152/eurjrheum.2015.0115
A case of systemic lupus erythematosus with multiple nodules in the bilateral lungs and vertebrae
(Eur J Rheumatol 2016; 3: 38-40)
DOI: 10.5152/eurjrheum.2015.0026
Chondrodermatitis nodularis chronica helicis in a patient with systemic sclerosis associated with primary biliary cirrhosis (Reynolds syndrome): A case report
(Eur J Rheumatol 2014; 1: 161-163)
DOI: 10.5152/eurjrheumatol.2014.140048
Study of systemic disease IgG4. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose –positron emission tomography/computed tomography for staging, selection of biopsy site , evaluation of treatment response and follow-up
(Eur J Rheumatol 2017; 4: 222-225)
DOI: 10.5152/eurjrheum.2017.16118
A case of central nervous system nocardiosis in a patient with lupus treated with belimumab
(Eur J Rheumatol 2016; 3: 188-190)
DOI: 10.5152/eurjrheum.2016.15083
Aneurysm of the ascending aorta in systemic lupus erythematosus: Case report and review of the literature
(Eur J Rheumatol 2017; 4: 133-135)
DOI: 10.5152/eurjrheum.2017.17066
Atrial fibrillation following therapy with high-dose i.v. methylprednisolone: A brief case-based review
(Eur J Rheumatol 2017; 4: 231-233)
DOI: 10.5152/eurjrheum.2017.16120
The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis
(Eur J Rheumatol 2017; 4: 68-69)
DOI: 10.5152/eurjrheum.2016.055
A rare cause of cytopenia in a patient with systemic lupus erythematosus: Autoimmune myelofibrosis
(Eur J Rheumatol 2017; 4: 76-78)
DOI: 10.5152/eurjrheum.2016.011
A report of three cases with lupus myelitis
(Eur J Rheumatol 2017; 4: 148-150)
DOI: 10.5152/eurjrheum.2017.160099
Inflammatory myopathy and autoimmune hepatitis in a patient with a flare of systemic lupus erythematosus: An exceptional association
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17135
Original Article
Humor in systemic lupus erythematosus
(Eur J Rheumatol 2015; 2: 5-9)
DOI: 10.5152/eurjrheumatol.2015.0070
The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus
(Eur J Rheumatol 2014; 1: 92-95)
DOI: 10.5152/eurjrheumatol.2014.032
Serum salusin-α levels in systemic lupus erythematosus and systemic sclerosis
(Eur J Rheumatol 2014; 1: 14-17)
DOI: 10.5152/eurjrheum.2014.004
Serum Soluble CD163 and its association with various disease parameters in patients with systemic sclerosis
(Eur J Rheumatol 2016; 3: 95-100)
DOI: 10.5152/eurjrheum.2016.15088
The implication of tissue Doppler echocardiography and cardiopulmonary exercise in early detection of cardiac dysfunction in systemic lupus erythematosus patients
(Eur J Rheumatol 2016; 3: 109-117)
DOI: 10.5152/eurjrheum.2016.16002
Low vitamin D status in systemic sclerosis and the impact on disease phenotype
(Eur J Rheumatol 2016; 3: 50-55)
DOI: 10.5152/eurjrheum.2015.0065
Differential assay reactivity of immunglobulin A anti-ß2 glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing
(Eur J Rheumatol 2015; 2: 135-138)
DOI: 10.5152/eurjrheum.2015.0012
Detailed features of hematological involvement and medication-induced cytopenia in systemic lupus erythematosus patients: single center results of 221 patients
(Eur J Rheumatol 2017; 4: 87-92)
DOI: 10.5152/eurjrheum.2017.160086
Impact of standard of care treatments and disease variables on outcomes in systemic lupus erythematosus trials: analysis from the Lupus Foundation of America Collective Data Analysis Initiative
(Eur J Rheumatol 2016; 3: 13-19)
DOI: 10.5152/eurjrheum.2015.0048
IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role
(Eur J Rheumatol 2017; 4: 29-35)
DOI: 10.5152/eurjrheum.2017.16059
Biomechanical podiatric evaluation in an Italian cohort of patients with systemic sclerosis: A pilot study
(Eur J Rheumatol 2016; 3: 169-174)
DOI: 10.5152/eurjrheum.2016.053
Therapeutic plasma exchange for refractory SLE: A comparison of outcomes between different sub-phenotypes
(Eur J Rheumatol 2018; 5: 32-36)
DOI: 10.5152/eurjrheum.2017.17088
Outcomes of rituximab therapy in refractory lupus: A meta-analysis
(Eur J Rheumatol 2018; 5: 118-126)
DOI: 10.5152/eurjrheum.2018.17096
Outcomes of rituximab therapy in refractory lupus: a meta-analysis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17096
Invited Review
Musculoskeletal involvement and ultrasonography update in systemic lupus erythematosus: New insights and review
(Eur J Rheumatol 2018; 5: 127-130)
DOI: 10.5152/eurjrheum.2017.17198
Key Words
Author’s Corner
AVES | Copyright © 2018 Medical Research and Education Association | Latest Update: 01.06.2018